Ghost Tree Capital’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-50,000
Closed -$5.08M 81
2017
Q3
$5.08M Sell
50,000
-75,000
-60% -$8.03M 1.08% 34
2017
Q2
$12.5M Buy
+125,000
New +$13.5M 2.6% 10
2015
Q4
Sell
-30,000
Closed -$2.74M 77
2015
Q3
$2.74M Sell
30,000
-45,000
-60% -$5M 1.23% 35
2015
Q2
$9.21M Buy
75,000
+30,000
+67% +$3.4M 2.99% 9
2015
Q1
$4.1M Buy
+45,000
New +$3.65M 1.47% 28
2014
Q4
Sell
-35,000
Closed -$2.83M 89
2014
Q3
$2.83M Buy
35,000
+15,000
+75% +$1.33M 1.54% 30
2014
Q2
$2.15M Sell
20,000
-5,000
-20% -$348K 1.51% 25
2014
Q1
$1.48M Buy
+25,000
New +$1.49M 0.88% 41

Other funds holding GWPH

Ghost Tree Capital's GWPH Position: Q4 2017 in Review

Ghost Tree Capital sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2017, closing a stake of 50,000 shares — an estimated $5.08M sold.

Ghost Tree Capital first reported a position in GWPH in Q1 2014 and held it in 8 quarters. The position peaked at $12.5M in Q2 2017. 204 funds tracked by Wall St. Rank hold GWPH as of Q4 2017.

  • Ghost Tree Capital reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2017 after selling out during the quarter.
  • Ghost Tree Capital sold 50,000 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2017, an estimated $5.08M.
  • Ghost Tree Capital first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2014 and held it in 8 quarters.
  • Ghost Tree Capital's GW Pharmaceuticals Plc American Depositary Shares position peaked at $12.5M in Q2 2017.
  • 204 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2017.

Based on Ghost Tree Capital's 13F filing for Q4 2017, filed 14 Feb 2018.